SOPHiA GENETICS will attend the European Congress of Pathology in Vienna, Austria, from September 6-9, 2025. At the event, they will present MSK-IMPACT® Flex powered with SOPHiA DDM™, a new solution designed to enhance comprehensive genomic profiling in precision oncology testing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief on September 07, 2025, and is solely responsible for the information contained therein.